EGFRi Combinations

NSCLC
» SNDX-275 with Erlotinib

AI Combinations

Breast Cancer
» SNDX-275 with Exemestane

DNA Methyltransferase Inhibitor Combinations

NSCLC
» SNDX-275 with Azacitidine

MDS, Chronic Myelomonocytic Leukemia, and/or AML
» SNDX-275 with Azacitidine
» SNDX-275 with or without Azacitidine

Growth Factor Combinations

MDS, Chronic Myelomonocytic Leukemia, and/or AML
» SNDX-275 and GM-CSF (NCI)
» SNDX-275 and GM-CSF (Johns Hopkins)

Single Agent Studies

Advanced Solid Tumors and Lymphomas
» SNDX-275